These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy. Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914 [TBL] [Abstract][Full Text] [Related]
44. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. Sun J; Zhao Y; Hu J PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622 [TBL] [Abstract][Full Text] [Related]
45. Glycerol Improves Skin Lesion Development in the Imiquimod Mouse Model of Psoriasis: Experimental Confirmation of Anecdotal Reports from Patients with Psoriasis. Choudhary V; Kaddour-Djebbar I; Custer VE; Uaratanawong R; Chen X; Cohen E; Yang R; Ajebo E; Hossack S; Bollag WB Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445455 [TBL] [Abstract][Full Text] [Related]
46. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789 [TBL] [Abstract][Full Text] [Related]
47. Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions. Algahtani MS; Ahmad MZ; Nourein IH; Ahmad J Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605030 [TBL] [Abstract][Full Text] [Related]
48. Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Kang NW; Kim MH; Sohn SY; Kim KT; Park JH; Lee SY; Lee JY; Kim DD Biomaterials; 2018 Nov; 182():245-258. PubMed ID: 30142524 [TBL] [Abstract][Full Text] [Related]
50. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice. Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482 [TBL] [Abstract][Full Text] [Related]
51. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants. Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048 [TBL] [Abstract][Full Text] [Related]
52. Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties. Pivetta TP; Simões S; Araújo MM; Carvalho T; Arruda C; Marcato PD Colloids Surf B Biointerfaces; 2018 Apr; 164():281-290. PubMed ID: 29413607 [TBL] [Abstract][Full Text] [Related]
53. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related]
54. Lenalidomide attenuates IMQ-induced inflammation in a mouse model of psoriasis. Jia HY; Qiu HY; Zhang MD; Hou JJ; Zhou ML; Wu Y Biomed Pharmacother; 2022 Dec; 156():113883. PubMed ID: 36270258 [TBL] [Abstract][Full Text] [Related]
55. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells. Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709 [TBL] [Abstract][Full Text] [Related]
56. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123 [TBL] [Abstract][Full Text] [Related]
57. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis. Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833 [TBL] [Abstract][Full Text] [Related]
58. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats. Rahman MA; Harwansh RK; Iqbal Z Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786 [TBL] [Abstract][Full Text] [Related]
59. Effect of Topical Application of Black Seed Oil on Imiquimod-Induced Psoriasis-like Lesions in the Thin Skin of Adult Male Albino Rats. Okasha EF; Bayomy NA; Abdelaziz EZ Anat Rec (Hoboken); 2018 Jan; 301(1):166-174. PubMed ID: 28926201 [TBL] [Abstract][Full Text] [Related]
60. Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model. Shobeiri SS; Rezaee M; Pordel S; Haghnnavaz N; Dashti M; Moghadam M; Sankian M Int Immunopharmacol; 2022 Sep; 110():108963. PubMed ID: 35724603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]